Skip to Content

N 739 150 (Mexiletine Hydrochloride 150 mg)

Pill with imprint N 739 150 is Tan / Orange, Capsule-shape and has been identified as Mexiletine Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Mexiletine is used in the treatment of ventricular tachycardia; myotonia congenita; diabetic peripheral neuropathy; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 739 150

Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150 Front
Mexiletine hydrochloride 150 mg N 739 150 Back

Mexiletine Hydrochloride

N 739 150
150 mg
Tan / Orange
18.00 mm
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
titanium dioxide
D&C Red No. 28
FD&C Blue No. 1
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0624 AvKare, Inc.
49999-0916 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.